Mark Alan Goldberg
CIK 1532475 · EVP, Medical & Reg. Strategy · last filed 2025-07-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
7
Total Filings
124
Lifetime Open-Market Net
-$6.10M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Blueprint Medicines Corp (BPMC) Delisted | Director | 0 | $129.46 | $0 | -$3.38M | 19 | 2025-07-21 |
| CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Director | 36,325 | $15.70 | $570.3K | $49.6K | 15 | 2024-05-01 |
| ImmunoGen, Inc. (IMGN) Delisted | Director | 0 | $31.23 | $0 | $242.6K | 50 | 2024-02-12 |
| Aceragen, Inc. (IDRA) Delisted | Director | 48,610 | $7.22 | $351.2K | $31.9K | 16 | 2022-06-27 |
| BOLD | Director | 0 | $1.41 | $0 | $0 | 4 | 2020-01-15 |
| LIFE | Director | — | $15.61 | — | $0 | 4 | 2017-05-11 |
| SYNAGEVA BIOPHARMA CORP (GEVA) Delisted | EVP, Medical & Reg. Strategy | 1,352 | — | — | -$3.04M | 16 | 2014-09-19 |
Recent Filings · Page 4 of 13
124 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-10 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-04 | Blueprint Medicines Corp (BPMC) Delisted | Grant (A) | +2,250 | $0 | EDGAR |
| 2021-05-27 | CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Grant (A) | +5,250 | $0 | EDGAR |
| 2021-04-05 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | +10,511 | $13.9K | EDGAR |
| 2021-04-02 | ImmunoGen, Inc. (IMGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-01-06 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | +3,452 | $13.9K | EDGAR |
| 2021-01-04 | ImmunoGen, Inc. (IMGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-12-28 | Blueprint Medicines Corp (BPMC) Delisted | Mixed | — | -$528.3K | EDGAR |
| 2020-12-22 | Blueprint Medicines Corp (BPMC) Delisted | Mixed | — | -$500.9K | EDGAR |
| 2020-12-15 | Blueprint Medicines Corp (BPMC) Delisted | Mixed | — | -$473.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.